Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Clinical trial NCT07361484 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07361484
Sponsor: BeyondSpring Pharmaceuticals Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Non-squamous Non-Small Cell Lung Cance

Start date: 2026-06-01
Primary completion: 2029-06-01
Enrollment: 442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.